ACTA VETERINARIA ET ZOOTECHNICA SINICA ›› 2017, Vol. 48 ›› Issue (3): 508-514.doi: 10.11843/j.issn.0366-6964.2017.03.014

Previous Articles     Next Articles

Studies on Presentation of Recombinant Parvovirus-like Particles by Porcine Splenic Dendritic Cells

LUO Shang-xing1, SHEN Xiao-qiang1, GU Wen-yuan1, 3, FAN Jing-hui1* , DI Jing-mei1, LIU Bao-jing1, DAI Fei1, KONG Yuan-yuan1, CHANG Yan-yan1, ZUO Yu-zhu1,2*   

  1. (1. College of Veterinary Medicine, Agricultural University of Hebei, Baoding 071001, China; 2. College of Animal Science and Technology, Agricultural University of Hebei, Baoding 071001, China; 3.Animal Disease Control and Prevention Center of Hebei, Shijiazhuang 050035, China)
  • Received:2016-10-09 Online:2017-03-23 Published:2017-03-22

Abstract:

In order to decipher the mechanism of PPV-VLP presentation by dendritic cells (DCs), CD172a+ CD11R+ DC and CD4- CD8+ T cell were isolated from spleen of unvaccinated and CSFV vaccinated pigs, respectively, using magnetic beads. Purified splenic DCs were preincubated for 1 h with primaquin, cycloheximide, chloroquine, lactacystin, brefeldin A, leupeptin, or pepstatin. Then PPV-VLPs-E290 was added, and the DCs were incubated for 4 h in the continued presence of these different drugs. The presentation assay of PPV-VLPs-E290 was monitored by cytotoxic activity of CD8+ T cells, which was measured using the Lactate dehydrogenase (LDH) release assay. The results showed that incubation of DCs with PPV-VLPs-E290 in the presence of primaquin and leupetin did not block PPV-VLPs-E290 presentation. However, the present efficiency of DCs pretreated with chloroquin, cycloheximide, brefeldin A and lactacystin was severely reduced. These results showed that DCs can cross-present PPV-VLPs-E290. Both acidification of late endosomes and protease hydrolysis are necessary for PPV-VLPs-E290 processing.

Key words: parvovirus-like particles, dendritic cells, presentation pathways

CLC Number: